AdipoRon ameliorates the progression of heart failure with preserved ejection fraction via mitigating lipid accumulation and fibrosis
Introduction: Obesity and imbalance in lipid homeostasis contribute greatly to heart failure with preserved ejection fraction (HFpEF), the dominant form of heart failure. Few effective therapies exist to control metabolic alterations and lipid homeostasis. Objectives: We aimed to investigate the car...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Journal of Advanced Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2090123224000778 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832595750127665152 |
|---|---|
| author | Wuping Tan Yijun Wang Siyi Cheng Zhihao Liu Mengjie Xie Lingpeng Song Qinfang Qiu Xiaofei Wang Zeyan Li Tianyuan Liu Fuding Guo Jun Wang Xiaoya Zhou |
| author_facet | Wuping Tan Yijun Wang Siyi Cheng Zhihao Liu Mengjie Xie Lingpeng Song Qinfang Qiu Xiaofei Wang Zeyan Li Tianyuan Liu Fuding Guo Jun Wang Xiaoya Zhou |
| author_sort | Wuping Tan |
| collection | DOAJ |
| description | Introduction: Obesity and imbalance in lipid homeostasis contribute greatly to heart failure with preserved ejection fraction (HFpEF), the dominant form of heart failure. Few effective therapies exist to control metabolic alterations and lipid homeostasis. Objectives: We aimed to investigate the cardioprotective roles of AdipoRon, the adiponectin receptor agonist, in regulating lipid accumulation in the two-hit HFpEF model. Methods: HFpEF mouse model was induced using 60 % high-fat diet plus L-NAME drinking water. Then, AdipoRon (50 mg/kg) or vehicle were administered by gavage to the two-hit HFpEF mouse model once daily for 4 weeks. Cardiac function was evaluated using echocardiography, and Postmortem analysis included RNA-sequencing, untargeted metabolomics, transmission electron microscopy and molecular biology methods. Results: Our study presents the pioneering evidence that AdipoR was downregulated and impaired fatty acid oxidation in the myocardia of HFpEF mice, which was associated with lipid metabolism as indicated by untargeted metabolomics. AdipoRon, orally active synthetic adiponectin receptor agonist, could upregulate AdipoR1/2 (independently of adiponectin) and reduce lipid droplet accumulation, and alleviate fibrosis to restore HFpEF phenotypes. Finally, AdipoRon primarily exerted its effects through restoring the balance of myocardial fatty acid intake, transport, and oxidation via the downstream AMPKα or PPARα signaling pathways. The protective effects of AdipoRon in HFpEF mice were reversed by compound C and GW6471, inhibitors of AMPKα and PPARα, respectively. Conclusions: AdipoRon ameliorated the HFpEF phenotype by promoting myocardial fatty acid oxidation, decreasing fatty acid transport, and inhibiting fibrosis via the upregulation of AdipoR and the activation of AdipoR1/AMPKα and AdipoR2/PPARα-related downstream pathways. These findings underscore the therapeutic potential of AdipoRon in HFpEF. Importantly, all these parameters get restored in the context of continued mechanical and metabolic stressors associated with HFpEF. |
| format | Article |
| id | doaj-art-4a09bbd9d4b548a799b4ebf8df06f2de |
| institution | Kabale University |
| issn | 2090-1232 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of Advanced Research |
| spelling | doaj-art-4a09bbd9d4b548a799b4ebf8df06f2de2025-01-18T05:04:19ZengElsevierJournal of Advanced Research2090-12322025-02-0168299315AdipoRon ameliorates the progression of heart failure with preserved ejection fraction via mitigating lipid accumulation and fibrosisWuping Tan0Yijun Wang1Siyi Cheng2Zhihao Liu3Mengjie Xie4Lingpeng Song5Qinfang Qiu6Xiaofei Wang7Zeyan Li8Tianyuan Liu9Fuding Guo10Jun Wang11Xiaoya Zhou12Department of Cardiology, Renmin Hospital of Wuhan University, China; Institute of Molecular Medicine, Renmin Hospital of Wuhan University, China; Hubei Key Laboratory of Autonomic Nervous System Modulation, China; Taikang Center for Life and Medical Sciences, Wuhan University, China; Cardiac Autonomic Nervous System Research Center of Wuhan University, China; Hubei Key Laboratory of Cardiology, China; Cardiovascular Research Institute, Wuhan University, Wuhan 430060, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, China; Institute of Molecular Medicine, Renmin Hospital of Wuhan University, China; Hubei Key Laboratory of Autonomic Nervous System Modulation, China; Taikang Center for Life and Medical Sciences, Wuhan University, China; Cardiac Autonomic Nervous System Research Center of Wuhan University, China; Hubei Key Laboratory of Cardiology, China; Cardiovascular Research Institute, Wuhan University, Wuhan 430060, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, China; Institute of Molecular Medicine, Renmin Hospital of Wuhan University, China; Hubei Key Laboratory of Autonomic Nervous System Modulation, China; Taikang Center for Life and Medical Sciences, Wuhan University, China; Cardiac Autonomic Nervous System Research Center of Wuhan University, China; Hubei Key Laboratory of Cardiology, China; Cardiovascular Research Institute, Wuhan University, Wuhan 430060, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, China; Institute of Molecular Medicine, Renmin Hospital of Wuhan University, China; Hubei Key Laboratory of Autonomic Nervous System Modulation, China; Taikang Center for Life and Medical Sciences, Wuhan University, China; Cardiac Autonomic Nervous System Research Center of Wuhan University, China; Hubei Key Laboratory of Cardiology, China; Cardiovascular Research Institute, Wuhan University, Wuhan 430060, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, China; Institute of Molecular Medicine, Renmin Hospital of Wuhan University, China; Hubei Key Laboratory of Autonomic Nervous System Modulation, China; Taikang Center for Life and Medical Sciences, Wuhan University, China; Cardiac Autonomic Nervous System Research Center of Wuhan University, China; Hubei Key Laboratory of Cardiology, China; Cardiovascular Research Institute, Wuhan University, Wuhan 430060, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, China; Institute of Molecular Medicine, Renmin Hospital of Wuhan University, China; Hubei Key Laboratory of Autonomic Nervous System Modulation, China; Taikang Center for Life and Medical Sciences, Wuhan University, China; Cardiac Autonomic Nervous System Research Center of Wuhan University, China; Hubei Key Laboratory of Cardiology, China; Cardiovascular Research Institute, Wuhan University, Wuhan 430060, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, China; Institute of Molecular Medicine, Renmin Hospital of Wuhan University, China; Hubei Key Laboratory of Autonomic Nervous System Modulation, China; Taikang Center for Life and Medical Sciences, Wuhan University, China; Cardiac Autonomic Nervous System Research Center of Wuhan University, China; Hubei Key Laboratory of Cardiology, China; Cardiovascular Research Institute, Wuhan University, Wuhan 430060, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, China; Institute of Molecular Medicine, Renmin Hospital of Wuhan University, China; Hubei Key Laboratory of Autonomic Nervous System Modulation, China; Taikang Center for Life and Medical Sciences, Wuhan University, China; Cardiac Autonomic Nervous System Research Center of Wuhan University, China; Hubei Key Laboratory of Cardiology, China; Cardiovascular Research Institute, Wuhan University, Wuhan 430060, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, China; Institute of Molecular Medicine, Renmin Hospital of Wuhan University, China; Hubei Key Laboratory of Autonomic Nervous System Modulation, China; Taikang Center for Life and Medical Sciences, Wuhan University, China; Cardiac Autonomic Nervous System Research Center of Wuhan University, China; Hubei Key Laboratory of Cardiology, China; Cardiovascular Research Institute, Wuhan University, Wuhan 430060, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, China; Institute of Molecular Medicine, Renmin Hospital of Wuhan University, China; Hubei Key Laboratory of Autonomic Nervous System Modulation, China; Taikang Center for Life and Medical Sciences, Wuhan University, China; Cardiac Autonomic Nervous System Research Center of Wuhan University, China; Hubei Key Laboratory of Cardiology, China; Cardiovascular Research Institute, Wuhan University, Wuhan 430060, ChinaDepartment of Cardiology, Renmin Hospital of Wuhan University, China; Institute of Molecular Medicine, Renmin Hospital of Wuhan University, China; Hubei Key Laboratory of Autonomic Nervous System Modulation, China; Taikang Center for Life and Medical Sciences, Wuhan University, China; Cardiac Autonomic Nervous System Research Center of Wuhan University, China; Hubei Key Laboratory of Cardiology, China; Cardiovascular Research Institute, Wuhan University, Wuhan 430060, China; Corresponding authors at: Department of Cardiology, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuhan City, Hubei Province 430060, China (X. Zhou, F. Guo), Department of Cardiology, The First Affiliated Hospital of Bengbu Medical College, No.287, Changhuai Road, Longzihu District, Bengbu, China (J. Wang).Department of Cardiology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China; Corresponding authors at: Department of Cardiology, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuhan City, Hubei Province 430060, China (X. Zhou, F. Guo), Department of Cardiology, The First Affiliated Hospital of Bengbu Medical College, No.287, Changhuai Road, Longzihu District, Bengbu, China (J. Wang).Department of Cardiology, Renmin Hospital of Wuhan University, China; Institute of Molecular Medicine, Renmin Hospital of Wuhan University, China; Hubei Key Laboratory of Autonomic Nervous System Modulation, China; Taikang Center for Life and Medical Sciences, Wuhan University, China; Cardiac Autonomic Nervous System Research Center of Wuhan University, China; Hubei Key Laboratory of Cardiology, China; Cardiovascular Research Institute, Wuhan University, Wuhan 430060, China; Corresponding authors at: Department of Cardiology, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuhan City, Hubei Province 430060, China (X. Zhou, F. Guo), Department of Cardiology, The First Affiliated Hospital of Bengbu Medical College, No.287, Changhuai Road, Longzihu District, Bengbu, China (J. Wang).Introduction: Obesity and imbalance in lipid homeostasis contribute greatly to heart failure with preserved ejection fraction (HFpEF), the dominant form of heart failure. Few effective therapies exist to control metabolic alterations and lipid homeostasis. Objectives: We aimed to investigate the cardioprotective roles of AdipoRon, the adiponectin receptor agonist, in regulating lipid accumulation in the two-hit HFpEF model. Methods: HFpEF mouse model was induced using 60 % high-fat diet plus L-NAME drinking water. Then, AdipoRon (50 mg/kg) or vehicle were administered by gavage to the two-hit HFpEF mouse model once daily for 4 weeks. Cardiac function was evaluated using echocardiography, and Postmortem analysis included RNA-sequencing, untargeted metabolomics, transmission electron microscopy and molecular biology methods. Results: Our study presents the pioneering evidence that AdipoR was downregulated and impaired fatty acid oxidation in the myocardia of HFpEF mice, which was associated with lipid metabolism as indicated by untargeted metabolomics. AdipoRon, orally active synthetic adiponectin receptor agonist, could upregulate AdipoR1/2 (independently of adiponectin) and reduce lipid droplet accumulation, and alleviate fibrosis to restore HFpEF phenotypes. Finally, AdipoRon primarily exerted its effects through restoring the balance of myocardial fatty acid intake, transport, and oxidation via the downstream AMPKα or PPARα signaling pathways. The protective effects of AdipoRon in HFpEF mice were reversed by compound C and GW6471, inhibitors of AMPKα and PPARα, respectively. Conclusions: AdipoRon ameliorated the HFpEF phenotype by promoting myocardial fatty acid oxidation, decreasing fatty acid transport, and inhibiting fibrosis via the upregulation of AdipoR and the activation of AdipoR1/AMPKα and AdipoR2/PPARα-related downstream pathways. These findings underscore the therapeutic potential of AdipoRon in HFpEF. Importantly, all these parameters get restored in the context of continued mechanical and metabolic stressors associated with HFpEF.http://www.sciencedirect.com/science/article/pii/S2090123224000778Heart failure with preserved ejection fractionFatty acid oxidationLipid accumulationAdipoRonMetabolic syndrome |
| spellingShingle | Wuping Tan Yijun Wang Siyi Cheng Zhihao Liu Mengjie Xie Lingpeng Song Qinfang Qiu Xiaofei Wang Zeyan Li Tianyuan Liu Fuding Guo Jun Wang Xiaoya Zhou AdipoRon ameliorates the progression of heart failure with preserved ejection fraction via mitigating lipid accumulation and fibrosis Journal of Advanced Research Heart failure with preserved ejection fraction Fatty acid oxidation Lipid accumulation AdipoRon Metabolic syndrome |
| title | AdipoRon ameliorates the progression of heart failure with preserved ejection fraction via mitigating lipid accumulation and fibrosis |
| title_full | AdipoRon ameliorates the progression of heart failure with preserved ejection fraction via mitigating lipid accumulation and fibrosis |
| title_fullStr | AdipoRon ameliorates the progression of heart failure with preserved ejection fraction via mitigating lipid accumulation and fibrosis |
| title_full_unstemmed | AdipoRon ameliorates the progression of heart failure with preserved ejection fraction via mitigating lipid accumulation and fibrosis |
| title_short | AdipoRon ameliorates the progression of heart failure with preserved ejection fraction via mitigating lipid accumulation and fibrosis |
| title_sort | adiporon ameliorates the progression of heart failure with preserved ejection fraction via mitigating lipid accumulation and fibrosis |
| topic | Heart failure with preserved ejection fraction Fatty acid oxidation Lipid accumulation AdipoRon Metabolic syndrome |
| url | http://www.sciencedirect.com/science/article/pii/S2090123224000778 |
| work_keys_str_mv | AT wupingtan adiporonamelioratestheprogressionofheartfailurewithpreservedejectionfractionviamitigatinglipidaccumulationandfibrosis AT yijunwang adiporonamelioratestheprogressionofheartfailurewithpreservedejectionfractionviamitigatinglipidaccumulationandfibrosis AT siyicheng adiporonamelioratestheprogressionofheartfailurewithpreservedejectionfractionviamitigatinglipidaccumulationandfibrosis AT zhihaoliu adiporonamelioratestheprogressionofheartfailurewithpreservedejectionfractionviamitigatinglipidaccumulationandfibrosis AT mengjiexie adiporonamelioratestheprogressionofheartfailurewithpreservedejectionfractionviamitigatinglipidaccumulationandfibrosis AT lingpengsong adiporonamelioratestheprogressionofheartfailurewithpreservedejectionfractionviamitigatinglipidaccumulationandfibrosis AT qinfangqiu adiporonamelioratestheprogressionofheartfailurewithpreservedejectionfractionviamitigatinglipidaccumulationandfibrosis AT xiaofeiwang adiporonamelioratestheprogressionofheartfailurewithpreservedejectionfractionviamitigatinglipidaccumulationandfibrosis AT zeyanli adiporonamelioratestheprogressionofheartfailurewithpreservedejectionfractionviamitigatinglipidaccumulationandfibrosis AT tianyuanliu adiporonamelioratestheprogressionofheartfailurewithpreservedejectionfractionviamitigatinglipidaccumulationandfibrosis AT fudingguo adiporonamelioratestheprogressionofheartfailurewithpreservedejectionfractionviamitigatinglipidaccumulationandfibrosis AT junwang adiporonamelioratestheprogressionofheartfailurewithpreservedejectionfractionviamitigatinglipidaccumulationandfibrosis AT xiaoyazhou adiporonamelioratestheprogressionofheartfailurewithpreservedejectionfractionviamitigatinglipidaccumulationandfibrosis |